In Depth
Over the horizon
What might be some of the outcomes of a ninth community pharmacy agreement, and what changes could these bring to community pharmacy? In the field of business, and in the …
Pharmacy in an AI world
Robots dispense. AI answers questions. What does a pharmacist do that technology cannot? The AJP’s chief pharmacist, Dr Brett MacFarlane asks As robots automate dispensing and AI delivers medicines information …
Research Roundup
Debbie Rigby rounds up the latest in research news Efficacy and safety of semaglutide according to frailty status This study found that semaglutide demonstrated beneficial effects on a broad range …
Eight billion reasons to protect one of Australia’s greatest healthcare achievements
Eighty years ago, Australians made a remarkable choice, writes Pharmacy Guild of Australia national president, Professor Trent Twomey In 1946, in the aftermath of war and amid hopes of building …
Lessons from pharmacist influencers
Pharmacists with large online followings share their words of wisdom for other professionals, including how to protect patients, deal with pushback and adhere to regulations If you have an audience …
From Sydney to the Olympic stage
The University of Sydney look at how alumnus, Dr Mark Stuart OBE, forged an unconventional career in pharmacy When Dr Mark Stuart OBE graduated from the University of Sydney with …
Is unity in pharmacy attainable?
It’s September 1946 and pharmacists are being warned that the progress of the profession may depend on disparate factions putting their differences aside to deliver a united front, the AJP reports. …
You think you’re safe – until you’re not
Artificial intelligence has seamlessly woven itself into our daily routines, impacting almost everything we do whether we realise it or not, Peak Strategies director Priya Narsing writes As business owners, …
Jellybeans or Balloons?
Pharmacies can be places of anxiety and stress, but there are ways to alleviate this. Though it may come at a cost, as Angelo Pricolo finds out If you spend …
dRx series: deprescribing cholinesterase inhibitors in older people
Amanda Quek and Amy Page
There are many factors to take into consideration when deprescribing cholinesterase inhibitors say Amanda Quek and Dr Amy Page Deprescribing is defined as a person-centred process of medication withdrawal intended …
Missed deadline may impact future licence applications
More than 500 pharmacy business licence applications submitted as deadline approaches, the Queensland Pharmacy Business Ownership Council reports The first year of licensing under the Pharmacy Business Ownership Act 2024 …
Research Roundup
Debbie Rigby rounds up the latest in research news Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes Current evidence does not support a cardiovascular benefit …